Manuscripts
Showing 1551 manuscripts.
Effects of negative life events on measures of quality of life and health utilization among children and youth with HIV infection.
Citation
Lois C. Howland, Sybil Crawford, Deborah S. Storm, Katherine Leung, Steven Gortmaker, James M. Oleske. Effects of negative life events on measures of quality of life and health utilization among children and youth with HIV infection.. Journal of the Association of Nurses in AIDS Care. 2007. 18: 3-11. PMID: 17338981Year
2007
Journal
Journal of the Association of Nurses in AIDS Care
Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS clinical trials group 5084
Citation
Jane Hitti, Janet Andersen, Grace McComsey, Tun Liu, Ann J. Melvin, Laura M. Smith, Alice M. Stek, Judith A. Aberg, Andrew D. Hull, Beverly L. Alston-Smith, Heather D. Watts, Elizabeth Livingston. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS clinical trials group 5084. American Journal of Obstetrics and Gynecology. 2007. 196: 331.e1-7.Year
2007
Journal
American Journal of Obstetrics and Gynecology
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115
Citation
Sharon A. Riddler, Hongyu Jiang, Allan R. Tenorio, Hairong Huang, Daniel R. Kuritzkes, Edward P. Acosta, Alan Landay, Barbara Bastow, David W. Haas, Karen T. Tashima, Mamta Khandelwal Jain, Steven G. Deeks, John Alexander Bartlett. A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115. Antiviral Therapy. 2007. 12: 531-41.Year
2007
Journal
Antiviral Therapy
The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine
Citation
Joseph J. Eron, Ronald J. Bosch, Daniel Bettendorf, Michael P. Bates, Leslie A. Petch, Susan A. Fiscus, Ian Frank. The effect of lamivudine therapy and M184V on the antiretroviral activity of didanosine. Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 249-51.Year
2007
Journal
Journal of Acquired Immune Deficiency Syndromes
The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection
Citation
David M. Margolis, Lisa Mukherjee, Courtney V. Fletcher, Evelyn Hogg, Debra M. Ogata-Arakaki, Tianna Petersen, Dave H. Rusin, Ana I. Martinez, John W. Mellors. The use of [beta]-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection. AIDS. 2007. 21: 2025-32.Year
2007
Journal
AIDS
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults
Citation
Judith Silverstein Currier, Michelle A. Kendall, W. Keith Henry, Beverly L. Alston-Smith, Francesca J. Torriani, Pablo Tebas, Yanjie Li, Howard N. Hodis. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007. 21: 1137-45.Year
2007
Journal
AIDS
Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression
Citation
Roy (Trip) Gulick, Christina M. Lalama, Heather Ribaudo, Cecilia M. Shikuma, Bruce R. Schackman, Jeffrey T. Schouten, Kathleen E. Squires, Susan L. Koletar, Christopher D. Pilcher, Richard C. Reichman, Karin L. Klingman, Daniel R. Kuritzkes. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression. AIDS. 2007. 21: 813-23.Year
2007
Journal
AIDS
Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087
Citation
Scott Evans, Carl J. Fichtenbaum, Judith A. Aberg. Comparison of direct and indirect measurement of LDL-C in HIV-infected individuals: ACTG 5087. HIV Clinical Trials. 2007. 8: 45-52.Year
2007
Journal
HIV Clinical Trials
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily
Citation
Edward P. Acosta, Michelle A. Kendall, John G. Gerber, Beverly L. Alston-Smith, Susan L. Koletar, Andrew R. Zolopa, Sangeeta Agarwala, Michael J. Child, Richard J. Bertz, Lara A. Hosey, David W. Haas. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrobial Agents and Chemotherapy. 2007. 51: 3104-10.Year
2007
Journal
Antimicrobial Agents and Chemotherapy
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090
Citation
Scott Evans, Tzu-min Yeh, Ned Sacktor, David B. Clifford, David M. Simpson, Eric N. Miller, Ronald J. Ellis, Victor G. Valcour, Christina M. Marra, Linda L. Millar, Giovanni Schifitto. Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090. HIV Clinical Trials. 2007. 8: 437-46.Year
2007
Journal
HIV Clinical Trials